PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Chloroform extract of the root reduced water immersion-induced gastric lesions in a dose-dependent manner in rats [PMID:24826000].
Ethanol extracts and solvent partitioned fractions of the root were investigated for anticonvulsant potential against pentylenetetrazole (PTZ) and maximal electroshock (MES) induced convulsions [PMID:24174820].
Crude methanol extracts of dried leaves displayed cytotoxicity against the MT-4 human leukaemia cancer cell line [PMID:21702230].
FSE and its compounds induced MCF-7 cell proliferation and trefoil factor 1 (pS2) expression [PMID:29797242].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 24826000 (2010) — Evaluation of anti-ulcerogenic properties from the root of Flemingia strobilifera. · Journal of basic and clinical pharmacy
- 2.PMID: 24174820 (2013) — Anticonvulsant potential of ethanol extracts and their solvent partitioned fractions from Flemingia strobilifera root. · Pharmacognosy research
- 3.PMID: 29797242 (2018) — Estrogenic effects of phytoestrogens derived from Flemingia strobilifera in MCF-7 cells and immature rats. · Archives of pharmacal research
- 4.PMID: 19645330 (2009) — Isoflavonoids from Flemingia strobilifera (L) R. Br. roots. · Acta poloniae pharmaceutica
- 5.PMID: 21702230 (2010) — Cytotoxic activity of selected West Indian medicinal plants against a human leukaemia cell line.